Pulmonary function tests, high-resolution computerized tomography, α1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis

Rheumatology International

Volumn 20, Issue 3, 2001, Pages 95-100

  Shahin, Amira A ^a   Sabri, Youssriah Y ^a   Mostafa, Heba A ^a   Sabry, Ehsan Y ^a   Hamid, Magdy A ^a   Gamal, Hany ^a   Shahin, Hesham A ^a  

^a Cairo University   (Egypt)

Author keywords

Alpha1 antitrypsin; BORG dyspnea score; High resolution CT; Reactive lung disease; Systemic sclerosis

Indexed keywords

ALPHA 1 ANTITRYPSIN; CARBON MONOXIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; LUNG VOLUME; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; SCORING SYSTEM; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; ALPHA 1-ANTITRYPSIN; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LUNG DISEASES; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035097012     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960000089     Document Type: Article

References (32)

1. Systemic sclerosis (scleroderma), localized scleroderma, eosiniphilic fasciitis, and calcinosis
2. Relationship between cutaneous and pulmonary involvement in systemic sclerosis
3. Mortality in systemic sclerosi (scleroderma)
4. Pulmonary involvement in systemic sclerosis: The detection of early changes by thin section CT scan, bronchoalveolar lavage and 99Tc-DTPA clearance
5. Serum immunoglobulins in liver disease
6. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage
7. 1 anti-protease complex in cystic fibrosis: Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
9. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
10. A service for the adult asthmatic
11. A step in the right direction. Assessing exercise tolerance in cystic fibrosis
12. Skin score: A semiquantitative measure of cutaneous involvement which improves prediction of prognosis in systemic sclerosis (SSc)
13. Spirometric standards for healthy nonsmoking adults
14. Pulmonary function in progressive systemic sclerosis
15. Severe restrictive lung disease in systemic sclerosis
16. Pulmonary involvement in progressive systemic sclerosis, sequential evaluation with CT, pulmonary function tests, and broncho-alveolar lavage
17. Isolated diffusing capacity reduction in systemic sclerosis
18. Imaging of pulmonary-cutaneous disorders: Matching the radiologic and dermatologic findings
19. Non-neoplastic parenchymal lung disease
20. Diffuse pulmonary disease
21. Fibrosing alveolitis, prognostic implication of groundglass attenuation of high resolution CT
22. Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: Response and survival
23. 1-antitrypsin as diagnostic and prognostic marker of acute pancreatitis: Clinical study in consecutive patients
24. 1-antitrypsin for diagnostic screening of inflammatory disorders
25. Antiproteases are increased in bronchoalveolar lavage in interstitial lung disease
26. 1-antitrypsin levels in sarcoidosis: Relationship to disease activity
27. Gallium-67 activity in BAL fluid in sarcoidosis
28. Bronchoalveolar lavage immunoglobulin A and G and antiproteases correlate with changes in diffusion indices during the natural course of pulmonary sarcoidosis
29. D-penicillamine therapy and interstitial lung disease in scleroderma
30. Acute and long-term effects of nifidipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease